Prognostic Value of the Residual SYNTAX Score on In-Hospital and Follow-Up Clinical Outcomes in ST Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventions

Table 1

In-hospital demographic, clinical, and laboratory characteristics and Grace Scores of patients.

Parameters	All patients (n : 538)	RSS = 0 (n : 131)	RSS < 7 (n: 188)	RSS ≥ 7 (n : 219)	value
Demographic parameters
Age (year)	61.9 ± 12.8	57.9 ± 12.4^a	60.8 ± 12.3^a	65.3 ± 12.7^b	<0.001
Male (n%)	422 (78.4)	100 (76.3)	149 (79.3)	173 (79)	0.796
Clinical history
HT (n%)	330 (61.3)	67 (51.1)^a	111 (59)^a,b	152 (69.4)^b	0.002
DM (n%)	255 (47.4)	46 (35.1)^a	85 (45.2)^a,b	124 (56.6)^b	<0.001
HL (n%)	326 (60.6)	72 (55)	115 (61.2)	139 (63.5)	0.283
CAD (n%)	122 (22.7)	23 (17.6)^a	37 (19.7)^a	62 (28.3)^b	0.032
Smoking (n%)	217 (40.3)	55 (42)	72 (38.3)	90 (41.1)	0.769
Clinical parameters
Anterior MI (n%)	256 (47.6)	64 (48.9)	97 (51.6)	95 (43.4)	0.240
Inferior MI (n%)	257 (47.8)	60 (45.8)	80 (42.6)	117 (53.4)	0.080
Other localization MI (n%)	25 (4.6)	7 (5.3)	11 (5.9)	7 (3.2)	0.407
SBP mm·Hg	131.3 ± 28.2	135.8 ± 23.3^a	137.5 ± 24.1^a	123.2 ± 32^b	<0.001
DBP mm·Hg	77.6 ± 16.4	79.4 ± 13.7^a	81.5 ± 15.1^a	73 ± 17.8^b	<0.001
Heart rate/min	82.5 ± 18.8	80.5 ± 16	81.2 ± 14.8	84.7 ± 22.9	0.065
Killip > 2 HF (n%)	102 (19)	8 (6.1)^a	15 (8)^a	79 (36.1)^b	<0.001
LVEF (%)	55 (45–60)	60 (54–65)^a	60 (50–60.5)^a	50 (38–60)^b	<0.001
Inotropic treatment (n%)	105 (19.5)	6 (4.6)^a	14 (7.4)^a	85 (38.8)^b	<0.001
IV diuretic treatment (n%)	79 (14.7)	7 (5.3)^a	18 (9.6)^a	54 (24.7)^b	<0.001
Gp2b3a treatment (n%)	86 (16)	15 (11.5)	31 (16.5)	40 (18.3)	0.236
IABP (n%)	23 (4.3)	0 (0)^a	2 (1.1)^a	21 (9.6)^b	<0.001
Grace Score	107 (87–130)	95 (80–109)^a	100 (81.5–122.5)^a	124 (106–146)^b	<0.001
Length of hospitalization (days)	5 (4–5)	4 (4-5)^a	4 (4-5)^a	5 (4–6)^b	0.008
Laboratory parameters
ABG level (mg/dl)	141 (115–197)	129 (105–187)^a	138 (117–188)^a	152 (124–225)^b	<0.001
FBG level (mg/dl)	108.5 (92–152)	98 (85–142)^a	107.5 (91–139)^a	118 (97–165)^b	<0.001
Hba1c	6.1 (5.6–7.3)	6 (5.5–6.9)^a	6 (5.6–6.85)^a	6.3 (5.7–8.1)^b	0.003
A-Cre level (mg/dl)	0.89 (0.76–1.03)	0.86 (0.74–0.98)^a	0.87 (0.75–1)^a	0.92 (0.8–1.13)^b	<0.001
PP-Cre level (mg/dl)	0.91 (0.8–1.11)	0.89 (0.79–1.02)^a	0.9 (0.79–1.03)^a	1 (0.8–1.42)^b	<0.001
CreCl (ml/min)	87.26 (69.09–99.01)	92.36 (81–102)^a	90.9 (78.38–101)^a	80 (63.15–93.96)^b	<0.001
Hb (g/dl)	13.94 ± 1.95	14.11 ± 1.8	14.1 ± 1.93	13.7 ± 2.02	0.065
WBC × 10^3	10.94 (8.63–13.5)	10.41 (8.02–13.04)^a	10.89 (8.37–12.8)^a	11.3 (9.2–14.45)^b	0.003
Neutrophil × 10^3	7.17 (5–9.8)	6.39 (4.6–8.68)^a	6.85 (5–9.63)^a,b	7.5 (5.73–10.44)^b	0.006
PLT × 10^3	254 (208–305)	262 (213–308)	248 (207–294.5)	253 (205–310)	0.493
CRP (mg/dl)	1.79 (0.6–6.58)	1.39 (0.5–4.2)^a	1.5 (0.57–5.12)^a	2.7 (0.7–11.1)^b	0.001
Peak Trop-T (ng/ml)	50000 (15.9–50000)	34.16 (8.1–50000)^a	50000 (13.7–50000)^b	50000 (35–50000)^c	<0.001
Peak Trop-T (ng/ml) > 50000 (n%)	283 (52.6)	50 (38.2)^a	95 (50.5)^b	138 (63)^c	<0.001

Data are presented as mean ± SD, median (0.250.75 percentiles), and n (%). ANOVA, Kruskal–Wallis test, and Pearson chi-square test were used and different letters show that there is a statistically significant difference. ABG: admission blood glucose, ACRE: admission creatinine, CAD: coronary artery disease, Cre: creatinine, CreCl: creatinine clearance, CRP: C-reactive protein, DBP: diastolic blood pressure, DM: diabetes mellitus, FBG: fasting blood glucose, Gp2b3a: glycoprotein 2b3a: antagonist, Hb: hemoglobin, HbA1C: hemoglobin A1C, HF: heart failure, HL: hyperlipidemia, HT: hypertension, IABP: intra-aortic balloon pump, IV: intravenous, LVEF: left ventricular ejection fraction, MI: myocardial infarction, PLT: platelet, PP-Cre: postprocedural creatinine, Trop: troponin, SBP: systolic blood pressure, and WBC: white blood cell.